WHO pilot study on the validity of imipramine platelet receptor binding sites as a biological marker of endogenous depression. A preliminary report on the initial evaluation phase of a World Health Organization Collaborative Study

Pharmacopsychiatry. 1988 May;21(3):147-50. doi: 10.1055/s-2007-1014667.
No abstract available

Publication types

  • Review

MeSH terms

  • Blood Platelets / metabolism*
  • Carrier Proteins*
  • Depressive Disorder / blood*
  • Humans
  • Imipramine / pharmacokinetics*
  • Radioligand Assay
  • Receptors, Drug*
  • Receptors, Neurotransmitter / metabolism*

Substances

  • Carrier Proteins
  • Receptors, Drug
  • Receptors, Neurotransmitter
  • imipramine receptor
  • Imipramine